logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

R. Hyland

Gilead Sciences
H指数:7
被引数:190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of Drug-Drug Interactions for Remdesivir, an Intravenous Antiviral for SARS-CoV-2, in Healthy Participants

Remdesivir（一种用于SARS-CoV-2的静脉注射抗病毒药物）在健康受试者中的药物相互作用特征研究

CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2025-11-120
OAAI
Chang, Jack; Kim, Aryun; Humeniuk, Rita; Shaik, Naveed A.; Winter, Helen; Peng, Chi-Chi; Xiao, Deqing; Abdelghany, Mazin; Llewellyn, Joe; Davies, Santosh; Golden, Kandace; Chen, Shuguang; Hyland, Robert H.; Caro, Luzelena
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients With Coronavirus Disease 2019 (BIRCH): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study

奥贝拉地韦在高风险非住院COVID-19患者中的疗效与安全性（BIRCH）：一项III期、随机、双盲、安慰剂对照研究

Clinical Infectious Diseases
IF7.3
2025-08-017
OA
Streinu-Cercel, Anca; Castagna, Antonella; Chang, Shan-Chwen; Chen, Yao-Shen; Koullias, Yiannis; Mozaffarian, Afsaneh; Hyland, Robert H.; Humeniuk, Rita; Caro, Luzelena; Davies, Santosh; Rodriguez, Lauren; Hedskog, Charlotte; Chen, Shuguang; Etchevers, Kim; Behenna-Renton, Nicole; Llewellyn, Joe; Osinusi, Anu; Duff, Frank; Barrat Hernandez, Alejandro; McNally, Damien; Simon-Campos, Jesus Abraham; Leal, Fabio Eudes; Fouche, Leon F.; Gonzalez Del Castillo, Juan Maria
Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial

Remdesivir对因冠状病毒疾病住院的肾功能受损患者的疗效和安全性2019肺炎: 一项随机临床试验

CLINICAL INFECTIOUS DISEASES
IF7.3
2024-06-244
OAAI
Sise, Meghan E.; Santos, Jose Ramon; Goldman, Jason D.; Tuttle, Katherine R.; Teixeira, J. Pedro; Seibert, Allan F.; Koullias, Yiannis; Llewellyn, Joe; Regan, Sean; Zhao, Yang; Huang, Hailin; Hyland, Robert H.; Osinusi, Anu; Winter, Helen; Humeniuk, Rita; Hulter, Henry N.; Gottlieb, Robert L.; Fusco, Dahlene N.; Birne, Rita; Stancampiano, Fernando F.; Libertin, Claudia R.; Small, Catherine B.; Plate, Markus; McPhail, Mark J.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2020-11-05969
OAAI
Goldman, Jason D.; Lye, David C. B.; Hui, David S.; Marks, Kristen M.; Bruno, Raffaele; Montejano, Rocio; Spinner, Christoph D.; Galli, Massimo; Ahn, Mi-Young; Nahass, Ronald G.; Chen, Yao-Shen; SenGupta, Devi; Hyland, Robert H.; Osinusi, Anu O.; Cao, Huyen; Blair, Christiana; Wei, Xuelian; Gaggar, Anuj; Brainard, Diana M.; Towner, William J.; Munoz, Jose; Mullane, Kathleen M.; Marty, Francisco M.; Tashima, Karen T.; Diaz, George; Subramanian, Aruna
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2020-10-0131
PREAI
Lawitz, Eric; Landis, Charles S.; Flamm, Steven L.; Bonacini, Maurizio; Ortiz-Lasanta, Grisell; Huang, Jonathan; Zhang, Jie; Kirby, Brian J.; De-Oertel, Shampa; Hyland, Robert H.; Osinusi, Anu O.; Brainard, Diana M.; Robson, Richard; Maliakkal, Benedict J.; Gordon, Stuart C.; Gane, Edward J.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2020-09-15962
OAAI
Spinner, Christoph D.; Gottlieb, Robert L.; Criner, Gerard J.; Arribas Lopez, Jose Ramon; Cattelan, Anna Maria; Soriano Viladomiu, Alex; Ogbuagu, Onyema; Malhotra, Prashant; Mullane, Kathleen M.; Castagna, Antonella; Chai, Louis Yi Ann; Roestenberg, Meta; Tsang, Owen Tak Yin; Bernasconi, Enos; Le Turnier, Paul; Chang, Shan-Chwen; SenGupta, Devi; Hyland, Robert H.; Osinusi, Anu O.; Cao, Huyen; Blair, Christiana; Wang, Hongyuan; Gaggar, Anuj; Brainard, Diana M.; McPhail, Mark J.; Bhagani, Sanjay; Ahn, Young; Sanyal, Arun J.; Huhn, Gregory; Marty, Francisco M.
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
JOURNAL OF HEPATOLOGY
IF33
2019-10-01111
OAAI
Borgia, Sergio M.; Dearden, Janet; Yoshida, Eric M.; Shafran, Stephen D.; Brown, Ashley; Ben-Ari, Ziv; Cramp, Matthew E.; Cooper, Curtis; Foxton, Matthew; Fernandez Rodriguez, Conrado; Esteban, Rafael; Hyland, Robert; Lu, Sophia; Kirby, Brian J.; Meng, Amy; Markova, Svetlana; Dvory-Sobol, Hadas; Osinusi, Anu O.; Bruck, Rafael; Ampuero, Javier; Ryder, Stephen D.; Agarwal, Kosh; Fox, Raymond; Shaw, David; Haider, Shariq; Willems, Bernard; Lurie, Yoav; Calleja, Jose Luis; Gane, Edward J.
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India
HEPATOLOGY INTERNATIONAL
IF6.1
2019-02-2114
OAAI
Sood, Ajit; Duseja, Ajay; Kabrawala, Mayank; Amrose, Pradeep; Goswami, Bhadadev; Chowdhury, Abhijit; Sarin, Shiv Kumar; Koshy, Abraham; Hyland, Robert H.; Lu, Sophia; Camus, Gregory; Stamm, Luisa M.; Brainard, Diana M.; Subramanian, G. Mani; Prasad, Madhura; Bhatia, Shobna; Shah, Samir R.; Kapoor, Dharmesh; Shalimar; Saraswat, Vivek
No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients
JOURNAL OF HEPATOLOGY
IF33
2018-12-0154
PREAI
Sarrazin, Christoph; Cooper, Curtis L.; Manns, Michael P.; Reddy, K. Rajender; Kowdley, Kris V.; Roberts, Stuart K.; Dvory-Sobol, Hadas; Svarovskia, Evguenia; Martin, Ross; Camus, Gregory; Doehle, Brian P.; Stamm, Luisa M.; Hyland, Robert H.; Brainard, Diana M.; Mo, Hongmei; Gordon, Stuart C.; Bourliere, Marc; Zeuzem, Stefan; Flamm, Steven L.
Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden
INFECTIOUS DISEASES
IF2.3
2018-11-3012
PREAI
Isakov, Vasily; Chulanov, Vladimir; Abdurakhmanov, Dzhamal; Burnevich, Eduard; Nurmukhametova, Elena; Kozhevnikova, Galina; Gankina, Natalya; Zhuravel, Sergey; Romanova, Svetlana; Hyland, Robert H.; Lu, Sophia; Svarovskaia, Evguenia S.; Mcnally, John; Brainard, Diana M.; Ivashkin, Vladimir; Morozov, Vyacheslav; Bakulin, Igor; Lagging, Martin; Zhdanov, Konstantin; Weiland, Ola
Deferred treatment with sofosbuvir-velpatasvir-voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2018-08-0125
PREAI
Bourliere, Marc; Gordon, Stuart C.; Schiff, Eugene R.; Tran, Tram T.; Ravendhran, Natarajan; Landis, Charles S.; Hyland, Robert H.; Stamm, Luisa M.; Zhang, Jie; Dvory-Sobol, Hadas; Subramanian, G. Mani; Brainard, Diana M.; McHutchison, John G.; Serfaty, Lawrence; Thompson, Alex J.; Sepe, Thomas E.; Curry, Michael P.; Reddy, K. Rajender; Manns, Michael P.

研究方向

暂未获取到该数据
D
Diana M. Brainard
H 指数:75论文数:487被引数:2.6万
J
John G. McHutchison
H 指数:125论文数:1,090被引数:7.7万
H
Hadas Dvory‐Sobol
H 指数:45论文数:146被引数:1.0万
W
William T. Symonds
H 指数:47论文数:221被引数:1.7万
E
Evguenia S. Svarovskaia
H 指数:49论文数:206被引数:1.1万
E
Edward Gane
H 指数:97论文数:726被引数:5.7万
E
Eric Lawitz
H 指数:0论文数:3被引数:151
G
G. Mani Subramanian
H 指数:69论文数:218被引数:2.5万
M
Marc Bourlière
H 指数:78论文数:654被引数:2.6万
L
Luisa M. Stamm
H 指数:33论文数:121被引数:4,301